Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fenfuro in Type 2 Diabetes
NCT03066089Phase 4Completed
- Sponsor
- Chemical Resources
- Start
- Dec 2015
- Primary completion
- Oct 2017
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial (2 arms), sponsored by Chemical Resources. Primary endpoints: Change in Fasting Blood Sugar at 12 weeks and Change in Postprandial sugar at 12 weeks. Started Dec 2015; status: completed.
Beyond the preview
Go deeper on NCT03066089.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03066089.